[Present and future of adjuvant hormone therapy in breast cancer: clinical evidence and clinical trials].
Zapatero
A
A
Servicio de Oncología Radioterápica. Hospital Universitario de La Princesa. Madrid. Spain. azapatero@hlpr.insalud.es
Martín de Vidales
C
C
Pérez-Torrubia
A
A
D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D000077289:Letrozole; D009570:Nitriles / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen; D000077384:Anastrozole; D000077289:Letrozole